Huiqin Liu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Biologics-device combinations: Enabling prolonged therapies in the posterior segment ocular disease.
Biologics-device combinations: Enabling prolonged therapies in the posterior segment ocular disease.
Journal: Advanced drug delivery reviews
Published: October 12, 2025
Supramolecular Self-Assembled Multivalent Anti-VEGF Protein Nanospheres for Prolonged Ocular Retention.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: June 15, 2025
Albumin-conjugated flumethasone for targeting and normalization of pancreatic stellate cells.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 29, 2024
Exploiting macropinocytosis for drug delivery into KRAS mutant cancer.
Journal: Theranostics
Published: October 09, 2021
Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer.
Journal: Theranostics
Published: July 24, 2021
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Journal: Advanced drug delivery reviews
Published: November 20, 2020
Albumin-conjugated drug is irresistible by single gene mutation of endocytic system: Verification by genome-wide CRISPR-Cas9 loss-of-function screens.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 25, 2020
KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 27, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026